skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Cases of HIV Infection and AIDS in the United States, by Race/Ethnicity, 1998–2002
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 11. Reported cases of HIV/AIDS for male adults and adolescents, by race/ethnicity and exposure category,1999–2002—30 areas with confidential name-based HIV infection reporting
spacer
spacer
View PDF PDF icon

  Year of diagnosis
Exposure category 1999 2000 2001 2002
  White, not Hispanic
Male-to-male sexual contact 5,480 4,859 5,063 5,095
Injection drug use 695 549 572 475
Male-to-male sexual contact and injection drug use 553 469 369 358
Hemophilia/coagulation disorder 36 29 24 17
Heterosexual contact 368 296 308 242
Sex with injection drug user 84 82 56 59
Sex with person with hemophilia 0 2 0 0
Sex with HIV-infected transfusion recipient 2 1 3 4
Sex with HIV-infected person, risk not specified 282 211 249 179
Receipt of blood transfusion, blood components, or tissue 40 32 34 31
Other/risk not reported or identifieda 1,297 1,263 1,264 1,776
Total 8,469 7,497 7,634 7,994
  Black, not Hispanic
Male-to-male sexual contact 3,052 2,810 2,877 2,716
Injection drug use 1,364 1,185 933 787
Male-to-male sexual contact and injection drug use 334 238 249 188
Hemophilia/coagulation disorder 14 5 7 4
Heterosexual contact 1,762 1,649 1,517 1,254
Sex with injection drug user 279 225 215 147
Sex with person with hemophilia 6 1 3 1
Sex with HIV-infected transfusion recipient 9 5 8 12
Sex with HIV-infected person, risk not specified 1,468 1,418 1,291 1,094
Receipt of blood transfusion, blood components, or tissue 43 38 24 29
Other/risk not reported or identifieda 3,307 3,048 3,282 3,915
Total 9,876 8,973 8,889 8,893
  Hispanic
Male-to-male sexual contact 1,134 1,062 1,115 1,224
Injection drug use 335 314 324 257
Male-to-male sexual contact and injection drug use 96 78 68 57
Hemophilia/coagulation disorder 1 2 0 2
Heterosexual contact 241 209 242 207
Sex with injection drug user 42 42 32 34
Sex with person with hemophilia 0 0 0 1
Sex with HIV-infected transfusion recipient 0 3 2 2
Sex with HIV-infected person, risk not specified 199 164 208 170
Receipt of blood transfusion, blood components, or tissue 8 4 5 8
Other/risk not reported or identifieda 604 654 677 787
Total 2,419 2,323 2,431 2,542
  Asian/Pacific Islander
Male-to-male sexual contact 60 42 58 64
Injection drug use 4 4 7 2
Male-to-male sexual contact and injection drug use 1 1 3 2
Hemophilia/coagulation disorder 0 0 0 1
Heterosexual contact 13 10 9 8
Sex with injection drug user 3 0 0 0
Sex with person with hemophilia 0 0 0 0
Sex with HIV-infected transfusion recipient 0 0 1 0
Sex with HIV-infected person, risk not specified 10 10 8 8
Receipt of blood transfusion, blood components, or tissue 1 0 1 0
Other/risk not reported or identifieda 21 44 37 45
Total 100 101 115 122
  American Indian/Alaska Native
Male-to-male sexual contact 77 65 55 68
Injection drug use 17 15 17 15
Male-to-male sexual contact and injection drug use 19 10 21 8
Hemophilia/coagulation disorder 0 0 0 0
Heterosexual contact 13 10 11 8
Sex with injection drug user 3 3 5 3
Sex with person with hemophilia 0 0 0 0
Sex with HIV-infected transfusion recipient 1 0 0 0
Sex with HIV-infected person, risk not specified 9 7 6 5
Receipt of blood transfusion, blood components, or tissue 1 0 1 0
Other/risk not reported or identifieda 22 13 17 18
Total 149 113 122 117
Total casesb 21,112 19,143 19,406 19,678
Data include male adults and adolescents with a diagnosis of HIV infection. This includes male adults and adolescents with a diagnosis of HIV infection (not AIDS), a diagnosis of HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
a Includes hemophilia, blood transfusion, perinatal, and risk not reported or not identified.
b Includes male adults and adolescents of unknown race or multiple races.
Last Modified: June 14, 2006
Last Reviewed: June 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services